1. Home
  2. BTOC vs APRE Comparison

BTOC vs APRE Comparison

Compare BTOC & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

HOLD

Current Price

$0.28

Market Cap

12.9M

Sector

N/A

ML Signal

HOLD

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

11.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTOC
APRE
Founded
2020
2006
Country
United States
United States
Employees
N/A
8
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
11.5M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
BTOC
APRE
Price
$0.28
$0.79
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$2.00
$4.10
AVG Volume (30 Days)
196.1K
191.7K
Earning Date
05-24-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.22
EPS
N/A
N/A
Revenue
$190,408,258.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.03
N/A
52 Week Low
$0.23
$0.55
52 Week High
$1.78
$2.22

Technical Indicators

Market Signals
Indicator
BTOC
APRE
Relative Strength Index (RSI) 47.54 43.25
Support Level $0.27 $0.75
Resistance Level $0.34 $0.81
Average True Range (ATR) 0.02 0.08
MACD -0.00 -0.01
Stochastic Oscillator 21.44 6.77

Price Performance

Historical Comparison
BTOC
APRE

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

Share on Social Networks: